Literature DB >> 8927712

Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity.

B G Wouters1, A M Sy, L D Skarsgard.   

Abstract

It is well known that cells of human tumor cell lines display a wide range of sensitivity to radiation, at least a part of which can be attributed to different capacities to process and repair radiation damage correctly. We have examined the response to very low-dose radiation of cells of five human tumor cell lines that display varying sensitivity to radiation, using an improved assay for measurement of radiation survival. This assay improves on the precision of conventional techniques by accurately determining the numbers of cells at risk, and has allowed us to measure radiation survival to doses as low as 0.05 Gy. Because of the statistical limitations in measuring radiation survival at very low doses, extensive averaging of data was used to determine the survival response accurately. Our results show that the four most resistant cell lines exhibit a region of initial low-dose hypersensitivity. This hypersensitivity is followed by an increase in radioresistance over the dose range 0.3 to 0.7 Gy, beyond which the response is typical of that seen in most survival curves. Mathematical modeling of the responses suggests that this phenomenon is not due to a small subpopulation of sensitive cells (e.g. mitotic), but rather is a reflection of the induction of resistance in the whole cell population, or at least a significant proportion of the whole cell population. These results suggest that a dose-dependent alteration in the processing of DNA damage over the initial low-dose region of cell survival may contribute to radioresistance in some cell lines.

Entities:  

Mesh:

Year:  1996        PMID: 8927712

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  22 in total

1.  A Logarithmic Formula to Describe the Relationship between the Increased Radiosensitivity at Low Doses and the Survival at 2 Gray.

Authors:  Faika A Azooz; Suzan K Hashim
Journal:  Sultan Qaboos Univ Med J       Date:  2013-11-08

2.  Modeling of cell inactivation and carcinogenesis in the atomic bomb survivors with applications to the mortality from all solid, stomach and liver cancer.

Authors:  Peter Jacob; Linda Walsh; Markus Eidemüller
Journal:  Radiat Environ Biophys       Date:  2008-05-15       Impact factor: 1.925

3.  A reaction-diffusion model for radiation-induced bystander effects.

Authors:  Oluwole Olobatuyi; Gerda de Vries; Thomas Hillen
Journal:  J Math Biol       Date:  2016-12-29       Impact factor: 2.259

4.  Low-dose radiation hyper-radiosensitivity in multicellular tumour spheroids.

Authors:  D Guirado; M Aranda; M Ortiz; J A Mesa; L I Zamora; E Amaya; M Villalobos; A M Lallena
Journal:  Br J Radiol       Date:  2012-10       Impact factor: 3.039

5.  Factors that determine local control with gamma knife radiosurgery: The role of primary histology.

Authors:  Paul J Black; Brandi R Page; John T Lucas; Ryan T Hughes; Adrian W Laxton; Stephen B Tatter; Michael T Munley; Michael D Chan
Journal:  J Radiosurg SBRT       Date:  2015

6.  Comparison of two radiation techniques for the breast boost in patients undergoing neoadjuvant treatment for breast cancer.

Authors:  Maria C De Santis; Luigia Nardone; Barbara Diletto; Roberta Canna; Michela Dispinzieri; Lorenza Marino; Laura Lozza; Vincenzo Valentini
Journal:  Br J Radiol       Date:  2016-07-25       Impact factor: 3.039

7.  Effects of G2-checkpoint dynamics on low-dose hyper-radiosensitivity.

Authors:  Oluwole Olobatuyi; Gerda de Vries; Thomas Hillen
Journal:  J Math Biol       Date:  2018-04-20       Impact factor: 2.259

8.  LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.

Authors:  Ji-An Yang; Bao-Hui Liu; Ling-Min Shao; Zhen-Tao Guo; Qian Yang; Li-Quan Wu; Bao-Wei Ji; Xiao-Nan Zhu; Shen-Qi Zhang; Cheng-Jun Li; Qian-Xue Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

9.  Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.

Authors:  David Eriksson; Homa Mirzaie Joniani; Ali Sheikholvaezin; Per-Olov Löfroth; Lennart Johansson; Katrine Riklund Ahlström; Torgny Stigbrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-30       Impact factor: 9.236

10.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.